Sientra (NASDAQ:SIEN) was upgraded by BidaskClub from a “sell” rating to a “hold” rating in a research report issued on Friday.
A number of other research analysts have also recently issued reports on SIEN. Canaccord Genuity started coverage on shares of Sientra in a report on Monday, August 28th. They issued a “buy” rating and a $14.00 price target for the company. William Blair raised shares of Sientra from a “market perform” rating to an “outperform” rating in a report on Wednesday, September 13th. Finally, Stifel Nicolaus reaffirmed a “hold” rating and issued a $14.00 price target (up previously from $11.00) on shares of Sientra in a report on Wednesday, September 27th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the stock. Sientra presently has a consensus rating of “Hold” and an average price target of $13.75.
Shares of Sientra (NASDAQ:SIEN) opened at $14.88 on Friday. Sientra has a one year low of $7.20 and a one year high of $16.68. The company has a quick ratio of 1.92, a current ratio of 2.87 and a debt-to-equity ratio of 0.57.
Sientra (NASDAQ:SIEN) last announced its earnings results on Tuesday, November 7th. The medical instruments supplier reported ($0.74) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.68) by ($0.06). The firm had revenue of $9.80 million during the quarter, compared to analyst estimates of $10.54 million. Sientra had a negative net margin of 169.77% and a negative return on equity of 68.82%. Sientra’s revenue was up 50.8% on a year-over-year basis. During the same quarter last year, the business earned ($0.55) earnings per share. sell-side analysts expect that Sientra will post -3.24 EPS for the current fiscal year.
Several hedge funds and other institutional investors have recently bought and sold shares of SIEN. Bamco Inc. NY raised its holdings in shares of Sientra by 109.3% in the second quarter. Bamco Inc. NY now owns 471,500 shares of the medical instruments supplier’s stock worth $4,583,000 after buying an additional 246,183 shares during the last quarter. EAM Investors LLC purchased a new position in shares of Sientra during the third quarter worth $3,018,000. Pura Vida Investments LLC purchased a new position in shares of Sientra during the third quarter worth $2,892,000. State Street Corp purchased a new position in shares of Sientra during the second quarter worth $1,449,000. Finally, Northern Trust Corp raised its holdings in shares of Sientra by 449.4% during the second quarter. Northern Trust Corp now owns 149,227 shares of the medical instruments supplier’s stock worth $1,451,000 after purchasing an additional 122,066 shares during the last quarter. 76.63% of the stock is owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION WARNING: This story was first reported by Transcript Daily and is the property of of Transcript Daily. If you are viewing this story on another publication, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this story can be read at https://transcriptdaily.com/2017/12/15/sientra-sien-upgraded-to-hold-at-bidaskclub.html.
Sientra, Inc is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons.
Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.